| Literature DB >> 31752209 |
Ping-Zhen Xu1,2, Mei-Rong Zhang1,2, Li Gao1, Yang-Chun Wu1,2, He-Ying Qian1,2, Gang Li1,2, An-Ying Xu1,2.
Abstract
The silkworm maggot, Exorista sorbillans, is a well-known larval endoparasitoid of the silkworm Bombyx mori that causes considerable damage to the silkworm cocoon crop. To gain insights into the response mechanism of the silkworm at the protein level, we applied a comparative proteomic approach to investigate proteomic differences in the hemolymph of the female silkworm pupae parasitized by E. sorbillans. In total, 50 differentially expressed proteins (DEPs) were successfully identified, of which 36 proteins were upregulated and 14 proteins were downregulated in response to parasitoid infection. These proteins are mainly involved in disease, energy metabolism, signaling pathways, and amino acid metabolism. Eight innate immune proteins were distinctly upregulated to resist maggot parasitism. Apoptosis-related proteins of cathepsin B and 14-3-3 zeta were significantly downregulated in E. sorbillans-parasitized silkworm pupae; their downregulation induces apoptosis. Quantitative PCR was used to further verify gene transcription of five DEPs, and the results are consistent at the transcriptional and proteomic levels. This was the first report on identification of possible proteins from the E. bombycis-parasitized silkworms at the late stage of parasitism, which contributes to furthering our understanding of the response mechanism of silkworms to parasitism and dipteran parasitoid biology.Entities:
Keywords: Bombyx mori; Exorista sorbillans; parasitoid; proteomics; two-dimensional gel electrophoresis
Year: 2019 PMID: 31752209 PMCID: PMC6920964 DOI: 10.3390/insects10110413
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
Figure 1Two-dimensional gel electrophoresis (2-DE) maps of the control and infected hemolymph collected from day-1 female silkworm pupae: The differentially expressed proteins (DEPs) are indicated by circles and numeric labels, which correspond to the numbers presented in Table 1. All samples were processed in parallel.
Data of the 50 DEPs identified by MALDI-TOF/TOF-MS/MS.
| Spot No. | Protein Name | SilkDB Accession No. | NCBI | Theoretical | Sequence | Peptides | Fold | Signal | Function |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| 1 | phenoloxidase subunit 2 precursor | BGIBMGA013115-PA | gi|112983448 | 80.12/5.62 | 18 | 11 | 3.66 | - | Serine protease involved in melanization |
| 2 | very low-density lipoprotein receptor isoform 1 precursor | BGIBMGA006214-PA | gi|160333138 | 61.54/5.20 | 4 | 3 | 4.53 | - | Chitin metabolic |
| 3 | 60 kDa heat shock protein, mitochondrial-like | BGIBMGA007349-PA | gi|512896628 | 61.06/5.51 | 22 | 8 | 2.61 | - | Protein refolding |
| 4 | paralytic peptide binding protein | BGIBMGA010168-PA | gi|112983896 | 50.01/6.33 | 30 | 11 | 3.17 | - | Extracellular region |
| 5 | uncharacterized protein LOC101739845 | BGIBMGA002604-PA | gi|512931715 | 49.40/5.42 | 15 | 6 | 2.94 | - | Farnesoic acid o-methyltransferase |
| 6 | antitrypsin | BGIBMGA009953-PA | gi|253809709 | 43.43/5.41 | 26 | 8 | 9.88 | - | Peptidase inhibitor activity |
| 7 | failed axon connections isoform X1 | BGIBMGA000552-PA | gi|512921311 | 42.89/5.31 | 11 | 3 | 3.64 | - | N/A |
| 8 | proliferation-associated protein 2G4 | BGIBMGA002493-PA | gi|512926720 | 42.14/7.13 | 33 | 9 | 3.24 | - | Cellular process |
| 9 | DNA supercoiling factor | BGIBMGA001107-PA | gi|347326520 | 38.02/4.48 | 40 | 12 | 2.83 | - | Calcium ion binding |
| 10 | C-type lectin 10 | BGIBMGA006768-PA | gi|148298818 | 36.56/5.53 | 6 | 2 | 3.59 | - | Carbohydrate binding |
| 11 | 32 kDa apolipoprotein precursor | BGIBMGA002703-PA | gi|226501956 | 32.09/4.79 | 7 | 3 | 2.91 | 1 | Pigment binding |
| 12 | spermidine synthase | BGIBMGA005897-PA | gi|512899761 | 32.43/5.54 | 26 | 8 | 3.15 | - | Catalytic activity |
| 13 | small glutamine-rich tetratricopeptide repeat-containing protein alpha-like | BGIBMGA010000-PA | gi|827549620 | 31.43/4.88 | 8 | 2 | 5.77 | - | Protein binding |
| 14 | uncharacterized protein LOC778506 isoform X1 | — | gi|827559778 | 30.66/4.31 | 9 | 2 | 4.22 | - | Cell surface glycoprotein |
| 15 | gasp precursor | BGIBMGA007677-PA | gi|114052326 | 29.09/4.82 | 7 | 1 | 24.35 | 1 | Chitin binding |
| 16 | uncharacterized protein LOC778506 isoform X2 | — | gi|827559780 | 28.45/4.25 | 9 | 2 | 4.15 | 1 | N/A |
| 17 | low molecular mass 30 kDa lipoprotein 21G1 isoform X1 | BGIBMGA004395-PA | gi|827538310 | 30.24/6.84 | 33 | 9 | 5.78 | 1 | Extracellular region |
| 18 | low molecular 30 kDa lipoprotein PBMHPC-19-like precursor | BGIBMGA004398-PA | gi|525343846 | 28.50/5.72 | 13 | 3 | 5.77 | 1 | Extracellular region |
| 19 | charged multivesicular body protein 5 | BGIBMGA002470-PA | gi|512926615 | 25.26/4.71 | 16 | 2 | 4.34 | - | Protein transport |
| 20 | Rab7 | BGIBMGA007712-PA | gi|114051368 | 23.42/5.16 | 4 | 1 | 8.85 | - | Small GTPase mediated signal transduction |
| 21 | uncharacterized protein LOC101746349 | BGIBMGA006731-PA | gi|512923633 | 20.06/4.56 | 27 | 4 | 5.38 | 1 | N/A |
| 22 | apolipophorin III | BGIBMGA013108-PA | gi|112983018 | 20.73/9.04 | 29 | 7 | 7.04 | 1 | Defense response |
| 23 | translationallycontrolled tumor protein | BGIBMGA003073-PA | gi|112982880 | 19.86/4.66 | 13 | 2 | 31.59 | - | Pathogen binding |
| 24 | translation initiation factor 5A | BGIBMGA007469-PA | gi|112982832 | 17.52/5.16 | 14 | 2 | 2.93 | - | Translational frameshifting |
| 25 | abnormal wing disc-like protein | BGIBMGA007701-PA | gi|153791847 | 17.31/6.74 | 26 | 5 | 11.04 | - | Nucleoside diphosphate phosphorylation |
| 26 | cyclophilin-like protein | BGIBMGA002429-PA | gi|60592747 | 17.96/7.74 | 17 | 2 | 3.81 | - | Protein peptidyl-prolyl isomerization |
| 27 | peptidoglycan recognition protein | BGIBMGA008038-PA | gi|112983994 | 21.63/6.70 | 33 | 6 | 3.32 | 1 | N-acetylmuramoyl-L-alanine amidase activity |
| 28 | probable pterin-4-alpha-carbinolamine dehydratase | — | gi|512899129 | 17.93/9.94 | 30 | 3 | 18.51 | - | 4-α-hydroxytetrahydrobiopterin dehydratase activity |
| 29 | odorant-binding protein 6 isoform X1 | BGIBMGA008354-PA | gi|827551076 | 15.96/4.94 | 18 | 3 | 3.41 | 1 | Odorant binding |
| 30 | E3 ubiquitin-protein ligase ZNRF2 | BGIBMGA011980-PA | gi|512897556 | 21.91/5.42 | 7 | 1 | 4.56 | - | Zinc ion binding |
| 31 | ribosomal protein S12 | BGIBMGA004374-PA | gi|112982671 | 15.03/5.79 | 24 | 2 | 4.62 | - | Structural constituent of ribosome |
| 32 | chemosensory protein 4 precursor | BGIBMGA004045-PA | gi|112983094 | 14.55/5.17 | 8 | 1 | 2.51 | 1 | Transporters of pheromone/odor molecules |
| 33 | chemosensory protein 7 precursor | BGIBMGA004041-PA | gi|112983052 | 13.52/4.97 | 18 | 3 | 4.77 | - | Transporters of pheromone/odor molecules |
| 34 | FK506-binding protein | BGIBMGA004331-PA | gi|114051243 | 11.82/7.85 | 43 | 4 | 10.66 | - | Isomerase activity |
| 35 | uncharacterized protein LOC101736984 isoform X3 | BGIBMGA007627-PA | gi|512916631 | 11.18/5.02 | 9 | 1 | 3.53 | - | N/A |
| 36 | ubiquitin-like protein SMT3 | BGIBMGA011581-PA | gi|112983974 | 10.31/5.29 | 23 | 3 |
| - | Protein binding |
|
| |||||||||
| 37 | heat shock protein 83 | BGIBMGA004612-PA | gi|112983556 | 82.42/4.98 | 3 | 2 | 0.11 | - | Unfolded protein binding |
| 38 | ATP synthase | BGIBMGA001853-PA | gi|114052278 | 59.66/9.21 | 4 | 2 | 0.21 | - | ATP binding |
| 39 | serine proteinase-like protein isoform X1 | BGIBMGA009551-PA | gi|827563139 | 44.88/5.73 | 15 | 6 | 0.01 | 1 | Serine-type endopeptidase activity |
| 40 | ornithine aminotransferase, mitochondrial | BGIBMGA003564-PA | gi|512922127 | 44.70/6.36 | 5 | 2 | 0.21 | - | Pyridoxal phosphate binding |
| 41 | aldose 1-epimerase | BGIBMGA009232-PA | gi|512891308 | 39.71/5.88 | 27 | 7 | 0.28 | - | Transaminase activity |
| 42 | aldo-ketoreductase AKR2E4-like isoform X1 | BGIBMGA001348-PA | gi|512908850 | 38.99/5.82 | 10 | 5 | 0.26 | 1 | Oxidoreductase activity |
| 43 | cathepsin B | BGIBMGA007061-PA | gi|112983908 | 37.56/5.95 | 18 | 5 | 0.17 | - | Regulation of catalytic activity |
| 44 | aldose reductase-like isoform X1 | BGIBMGA012152-PA | gi|512901366 | 35.84/6.10 | 20 | 6 | 0.39 | - | Oxidoreductase activity |
| 45 | 14-3-3 protein zeta | BGIBMGA002644-PA | gi|114050901 | 28.17/4.90 | 6 | 2 | 0.21 | - | Protein domain specific binding |
| 46 | vacuolar ATP synthase subunit E | BGIBMGA010247-PA | gi|114052088 | 26.12/8.98 | 17 | 3 | 0.19 | - | ATP hydrolysis |
| 47 | tyrosine-protein phosphatase Lar | BGIBMGA012106-PA | gi|512933991 | 22.75/6.29 | 7 | 1 | 0.18 | 1 | Protein binding |
| 48 | diapause bioclock protein | BGIBMGA002907-PA | gi|68144076 | 18.29/6.12 | 27 | 3 | 0.15 | 1 | Superoxide dismutase activity |
| 49 | ecdysteroid-regulated 16 kDa protein precursor | BGIBMGA008405-PA | gi|151301100 | 15.82/5.92 | 12 | 1 | 0.01 | 1 | Ecdysteroid level regulated |
| 50 | chemosensory protein 5 precursor | BGIBMGA004065-PA | gi|112983054 | 14.26/6.89 | 22 | 3 | 0.23 | 1 | RNA-binding |
Note: - no signal peptide was predicted and no SilkDB accession number was found; N/A not applicable.
Figure 2Distribution of the Gene Ontology (GO) terms for all proteins identified from the control and infected hemolymph: The DEPs were classified into cellular component, molecular function, and biological process by GO.
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of DEPs.
| Number | Pathway | Pathway ID | Accession No. | Description | Fold Change |
|---|---|---|---|---|---|
| 1 | Galactose metabolism | ko00052 | gi|512891308 | aldose 1-epimerase | 0.28 |
| gi|512908850 | aldehyde reductase | 0.26 | |||
| gi|512901366 | aldehyde reductase | 0.39 | |||
| 2 | Huntington’s disease | ko05016 | gi|60592747 | peptidyl-prolyl isomerase | 3.81 |
| gi|114052278 | ATPase | 0.21 | |||
| gi|68144076 | superoxide dismutase | 0.15 | |||
| 3 | Glycerolipid metabolism | ko00561 | gi|512908850 | aldehyde reductase | 0.26 |
| gi|512901366 | aldehyde reductase | 0.39 | |||
| 4 | Longevity regulating pathway—worm | ko04212 | gi|512896628 | chaperonin | 2.61 |
| gi|114050901 | protein binding | 0.21 | |||
| 5 | Lysosome | ko04142 | gi|112983908 | cathepsin B | 0.17 |
| gi|151301100 | Niemann–Pick C2 protein | 0.01 | |||
| 6 | Pentose and glucuronate interconversions | ko00040 | gi|512908850 | aldehyde reductase | 0.26 |
| gi|512901366 | aldehyde reductase | 0.39 | |||
| 7 | Fructose and mannose metabolism | ko00051 | gi|512908850 | aldehyde reductase | 0.26 |
| gi|512901366 | aldehyde reductase | 0.39 | |||
| 8 | Parkinson’s disease | ko05012 | gi|60592747 | peptidyl-prolyl isomerase | 3.81 |
| gi|114052278 | ATPase | 0.21 | |||
| 9 | Amoebiasis | ko05146 | gi|253809709 | serpin B | 9.88 |
| gi|114051368 | Ras-related protein | 8.85 | |||
| 10 | Oxidative phosphorylation | ko00190 | gi|114052278 | ATPase | 0.21 |
| gi|114052088 | ATPase | 0.19 | |||
| 11 | Tuberculosis | ko05152 | gi|512896628 | chaperonin | 2.61 |
| gi|114051368 | Ras-related protein | 8.85 | |||
| 12 | Antigen processing and presentation | ko04612 | gi|112983556 | molecular chaperone | 0.11 |
| gi|112983908 | cathepsin B | 0.17 | |||
| 13 | Phagosome | ko04145 | gi|114051368 | Ras-related protein | 8.85 |
| gi|114052088 | ATPase | 0.19 | |||
| 14 | Endocytosis | ko04144 | gi|512926615 | charged multivesicular body protein | 4.34 |
| gi|114051368 | Ras-related protein | 8.85 | |||
| 15 | PI3K-Akt signaling pathway | ko04151 | gi|112983556 | molecular chaperone | 0.11 |
| gi|114050901 | protein binding | 0.21 | |||
| 16 | Arginine and proline metabolism | ko00330 | gi|512899761 | spermidine synthase | 3.15 |
| gi|512922127 | ornithine–oxo-acid transaminase | 0.21 | |||
| 17 | NOD-like receptor signaling pathway | ko04621 | gi|112983556 | molecular chaperone | 0.11 |
| 18 | Legionellosis | ko05134 | gi|512896628 | chaperonin | 2.61 |
| 19 | Epstein-Barr virus infection | ko05169 | gi|114050901 | protein binding | 0.21 |
| 20 | Glycolysis/Gluconeogenesis | ko00010 | gi|512891308 | aldose 1-epimerase | 0.28 |
Note: phosphatidylinositol-3-kinase (PI3K); phosphorylation of protein kinase B (Akt); nucleotide-binding and oligomerization domain (NOD).
Figure 3Expression profiles of five genes in the control and infected (A) hemocytes and (B) fat bodies collected from day-1 female silkworm pupae: For each gene, the transcriptional level of the control was set to 1. The data are the means ± SD of three independent experiments. Statistical analysis was performed using SPSS software. * p < 0.05, ** p < 0.01.